Johnson & Johnson (JNJ)

135.22
NYSE : Health Care
Prev Close 135.22
Day Low/High 0.00 / 0.00
52 Wk Low/High 109.32 / 137.08
Avg Volume 5.26M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 363.36B
EPS 6.00
P/E Ratio 22.75
Div & Yield 3.36 (2.50%)

Latest News

Johnson & Johnson Is Getting Ready for Another Upside Breakout

Johnson & Johnson Is Getting Ready for Another Upside Breakout

A cover shorts signal was triggered, and an outright go long signal could follow soon.

Shrug Off The Apple-FANG Bite: Cramer's 'Mad Money' Recap (Thur 9/14/17)

Shrug Off The Apple-FANG Bite: Cramer's 'Mad Money' Recap (Thur 9/14/17)

Jim Cramer says this not the end of the world for Apple and the FANG stocks. It's the start of a rotation, and smart investors need to know how to use it as a buying opportunity.

Cramer: Got the Apple-FANG Blues? Look for a Rotation

Cramer: Got the Apple-FANG Blues? Look for a Rotation

There's one going on now.

Johnson & Johnson Launches Dr. Paul Janssen Project To Catalyze And Convene Champions Of Science Across Generations And Geographies

Johnson & Johnson Launches Dr. Paul Janssen Project To Catalyze And Convene Champions Of Science Across Generations And Geographies

Shark Tank's Daymond John to Judge the First Champions of Science "What's New?" Challenge Multifaceted Platform to Broaden Public Engagement in Science

S&P 500 Reaches New Record as Stocks Rally Amid Subsiding Irma, North Korea Fears

S&P 500 Reaches New Record as Stocks Rally Amid Subsiding Irma, North Korea Fears

Wall Street starts the week with a rally.

Dow, S&P 500 on Track for Best Day in 6 Months as Irma Worries Ease

Dow, S&P 500 on Track for Best Day in 6 Months as Irma Worries Ease

The Dow is up more than 250 points.

Dow Trades Above 22,000 as Irma's Damage Estimates Lower Than Feared

Dow Trades Above 22,000 as Irma's Damage Estimates Lower Than Feared

Wall Street moves higher.

Achillion Shares Are Plunging on Termination of Hepatitis C Pact

Achillion Shares Are Plunging on Termination of Hepatitis C Pact

The New Haven, Conn.-based firm on Sept. 9 received a termination notice regarding its license and collaboration pact with Johnson & Johnson's Janssen Pharmaceuticals Inc. on hepatitis C.

There Is Still Likely a Push Back Down Coming

And currencies are the place I find most stretched.

Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar

Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar

U.S. companies that have significant sales in Europe are about to reap the benefits of a weak greenback.

How to Avoid Making One of the Most Lethal Investing Mistakes Around

How to Avoid Making One of the Most Lethal Investing Mistakes Around

You have to consider all risks when investing, especially this one.

Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar

Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar

U.S. companies that have significant sales in Europe are about to reap the benefits of a weak greenback.

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief

Corporations have contributed at least $141.3 million to aid Hurricane Harvey relief efforts, as of Friday.

Cramer: There Should Be More Takeovers Where These Came From

Cramer: There Should Be More Takeovers Where These Came From

Buying's good for the acquirers, which should give other companies ideas.

StoneMor Shares Have Fallen Like a Stone

But even at this low level, the stock is no bargain.

Play Defense, Play the Dollar: Cramer's 'Mad Money' Recap (Tuesday 8/29/17)

Play Defense, Play the Dollar: Cramer's 'Mad Money' Recap (Tuesday 8/29/17)

Jim Cramer says now the money can flow back to tech and healthcare, but take a pass on retail, oil and financials.

Cramer: Ready for the New Normal? Here It Is

Cramer: Ready for the New Normal? Here It Is

Problem areas such as the dollar, oil and retail move to the foreground.

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.

How JNJ's Chief Medical Officer Fell In Love With Science -- In a Bakery

How JNJ's Chief Medical Officer Fell In Love With Science -- In a Bakery

JNJ's Chief Medical Officer fell in love with science after spending so much time in her family's bakery

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers

The Emeryville, Calif.-based firm secures FDA approval for Gocovri as a treatment for dyskinesia in Parkinson's disease patients.

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

America's biggest hedge funds are worth over $6 trillion combined, and here are the most common stocks they're selling.

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

J&J's Janssen Pharmaceuticals will oppose Florida's use of its drug in a Thursday execution.

President Trump Outlines Plans for Fighting in Afghanistan

President Trump Outlines Plans for Fighting in Afghanistan

President Donald Trump said troop levels will be ramped up but no numbers were given.

J&J Slammed With $417 Million Verdict in California Talc Cancer Trial

J&J Slammed With $417 Million Verdict in California Talc Cancer Trial

The case was probing an alleged link between talc products and ovarian cancer.

CEOs Are Failing to Act Like Real Leaders In Taking Weak Stand Against Trump

CEOs Are Failing to Act Like Real Leaders In Taking Weak Stand Against Trump

CEOs were slow to respond even after Merck CEO Ken Frazier was the first executive to exit President Donald Trump's manufacturing council.

In Trump CEO Council Exodus, Early Movers Stand Out

In Trump CEO Council Exodus, Early Movers Stand Out

Some CEOs quit Trump's advisory councils before they were disbanded on Wednesday. Most waited until after.

Stocks Rise as CEOs Find They Can Denounce Trump and Survive

Stocks Rise as CEOs Find They Can Denounce Trump and Survive

Wednesday was not a good day for President Donald Trump. It wasn't half-bad for markets.

TheStreet Quant Rating: A (Buy)